Gallbladder cancer predisposition: A multigenic approach to DNA-repair, apoptotic and inflammatory pathway genes

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Srivastava, Kshitij ^a   Srivastava, Anvesha ^a   Kumar, Ashok ^a   Mittal, Balraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ASPARAGINE; ASPARTIC ACID; CASPASE 8; CYSTEINE; CYTOSINE; GUANINE; NUCLEAR PROTEIN; PROTEIN MSH2; PROTEIN OGG1; PROTEIN PTGS2; SERINE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TYROSINE; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM GROUP D PROTEIN; XRCC1 PROTEIN; CYCLOOXYGENASE 2; PTGS2 PROTEIN, HUMAN;

ADULT; AGED; ALLELE; APOPTOSIS; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONTROLLED STUDY; DNA REPAIR; FEMALE; GALLBLADDER CANCER; GENE DELETION; GENE INSERTION; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; GALLBLADDER TUMOR; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; INDIA; PATHOLOGY; TUMOR GENE;

ALLELES; APOPTOSIS; CASE-CONTROL STUDIES; CYCLOOXYGENASE 2; DNA REPAIR; GALLBLADDER NEOPLASMS; GENES, NEOPLASM; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDIA; INFLAMMATION; POLYMORPHISM, GENETIC;

EID: 79251616587     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016449     Document Type: Article

References (49)

1. Randi G, Franceschi S, La Vecchia C (2006) Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer 118: 1591-1602.
2. Lazcano-Ponce EC, Miquel JF, Munoz N, Herrero R, Ferrecio C, et al. (2001) Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin 51: 349-364.
3. Hsing AW, Gao YT, Han TQ, Rashid A, Sakoda LC, et al. (2007) Gallstones and the risk of biliary tract cancer: a population-based study in China. Br J Cancer 97: 1577-1582.
4. Srivastava K, Srivastava A, Pandey S, Kumar A, Mittal B (2009) Functional polymorphisms of the cyclooxygenase (PTGS2) gene and risk for gallbladder cancer in a North Indian population. J Gastroenterol 44: 774-780.
5. Srivastava K, Srivastava A, Mittal B (2010) Polymorphisms in ERCC2, MSH2, and OGG1 DNA Repair Genes and Gallbladder Cancer Risk in a Population of Northern India. Cancer (In Press).
6. Srivastava K, Srivastava A, Mittal B (2010) Polymorphisms in ERCC2, MSH2, and OGG1 DNA repair genes and gallbladder cancer risk in a population of Northern India. Cancer 116: 3160-3169.
7. Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, et al. (2001) Multifactor dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 69: 138-147.
8. Lunetta KL, Hayward LB, Segal J, Van Eerdewegh P (2004) Screening largescale association study data: exploiting interactions using random forests. BMC Genet 5: 32.
9. Jiao X, Huang J, Wu S, Lv M, Hu Y, et al. (2007) hOGG1 Ser326Cys polymorphism and susceptibility to gallbladder cancer in a Chinese population. Int J Cancer 121: 501-505.
10. Sanguansin S, Petmitr S, Punyarit P, Vorasubin V,Weerapradist W, et al. (2006) hMSH2 gene alterations associated with recurrence of oral squamous cell carcinoma. J Exp Clin Cancer Res 25: 251-257.
11. Bernard-Gallon D, Bosviel R, Delort L, Fontana L, Chamoux A, et al. (2008) DNA repair gene ERCC2 polymorphisms and associations with breast and ovarian cancer risk. Mol Cancer 7: 36.
12. Sakoda LC, Gao YT, Chen BE, Chen J, Rosenberg PS, et al. (2006) Prostaglandin-endoperoxide synthase 2 (PTGS2) gene polymorphisms and risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China. Carcinogenesis 27: 1251-1256.
13. Chen K, Huang J, Gong W, Iribarren P, Dunlop NM, et al. (2007) Toll-like receptors in inflammation, infection and cancer. Int Immunopharmacol 7: 1271-1285.
14. El-Omar EM, Ng MT, Hold GL (2008) Polymorphisms in Toll-like receptor genes and risk of cancer. Oncogene 27: 244-252.
15. International Union Against Cancer(UICC) (2002) TNM Classification of malignant tumours, 6th ed, Sobin LH, Wittekind Ch (ed.), New York, Wiley-Liss. pp 184-187.
16. Devlin B, Roeder K (1999) Genomic Control for Association Studies. Biometrics 55: 997-1004.
17. Armitage P (1995) Tests for linear trends in proportions and frequencies. Biometrics 11: 375-386.
18. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96: 434-442.
19. Steinberg D, Colla P (1995) CART: Tree-Structured Non-Parametric Data Analysis. San Diego, CA: Salford Systems.
20. Breiman L, Friedman J, Olshen R, Stone C (1984) Classification and Regression Trees. Pacific Grove: Wadsworth.
21. Manton KG, Woodbury MA, Tolley HD (1994) Statistical applications using fuzzy sets. New York: John Wiley & Sons.
22. Woodbury MA, Manton KG (1982) A new procedure for analysis of medical classification. Methods Inf Med 21: 210-220.
23. Corder EH, Blennow K, Prince JA (2008) Genetic susceptibility sets for Alzheimer's disease identified from diverse candidate loci. Rejuvenation Res 11: 667-679.
24. Yoshida S, Todoroki T, Ichikawa Y, Hanai S, Suzuki H, et al. (1995) Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers. Cancer Res 55: 2756-2760.
25. Ajiki T, Fujimori T, Onoyama H, Yamamoto M, Kitazawa S, et al. (1996) K-ras gene mutation in gall bladder carcinomas and dysplasia. Gut 38: 426-429.
26. Hanada K, Itoh M, Fujii K, Tsuchida A, Hirata M, et al. (1997) TP53 mutations in stage I gallbladder carcinoma with special attention to growth patterns. Eur J Cancer 33: 1136-1140.
27. Srivastava K, Srivastava A, Kumar A, Mittal B (2010) Significant association between toll-like receptor gene polymorphisms and gallbladder cancer. Liver International 30: 1067-1072.
28. Srivastava A, Srivastava K, Pandey S, Choudhuri G, Mittal B (2009) Single- Nucleotide Polymorphisms of DNA Repair Genes OGG1 and XRCC1: Association with Gallbladder Cancer in North Indian Population. Ann Surg Oncol 16: 1695-1703.
29. Hastie T, Tibshirani R, Friedman JH (2001) The elements of statistical learning: data mining, inference, and prediction. New York: Springer.
30. Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994) Mutations in the p53 Tumor Suppressor Gene: Clues to Cancer Etiology and Molecular Pathogenesis. Cancer Res 54: 4855-4878.
31. Kamiya H, Murata-Kamiya N, Koizume S, Inoue H, Nishimura S, et al. (1995) 8-Hydroxyguanine (7,8-dihydro-8-oxoguanine) in hot spots of the c-Ha-ras gene: effects of sequence contexts on mutation spectra. Carcinogenesis 16: 883-889.
32. Xing D, Tan W, Song N, Lin D (2000) [Genetic polymorphism in hOGG1 and susceptibility to esophageal cancer in Chinese]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 17: 377-380.
33. Park J, Chen L, Tockman MS, Elahi A, Lazarus P (2004) The human 8- oxoguanine DNA N-glycosylase 1 (hOGG1) DNA repair enzyme and its association with lung cancer risk. Pharmacogenetics 14: 103-109.
34. Arizono K, Osada Y, Kuroda Y (2008) DNA repair gene hOGG1 codon 326 and XRCC1 codon 399 polymorphisms and bladder cancer risk in a Japanese population. Jpn J Clin Oncol 38: 186-191.
35. Cai Q, Shu XO, Wen W, Courtney R, Dai Q, et al. (2006) Functional Ser326Cys polymorphism in the hOGG1 gene is not associated with breast cancer risk. Cancer Epidemiol Biomarkers Prev 15: 403-404.
36. Kim JI, Park YJ, Kim KH, Song BJ, Lee MS, et al. (2003) hOGG1 Ser326Cys polymorphism modifies the significance of the environmental risk factor for colon cancer. World J Gastroenterol 9: 956-960.
37. Fan CY, Liu KL, Huang HY, Barnes EL, Swalsky PA, et al. (2001) Frequent allelic imbalance and loss of protein expression of the DNA repair gene hOGG1 in head and neck squamous cell carcinoma. Lab Invest 81: 1429-1438.
38. Gasparini G, Longo R, Sarmiento R, Morabito A (2003) Inhibitors of cyclooxygenase 2: a new class of anticancer agents? The Lancet Oncology 4: 605-615.
39. Tazawa R, Xu XM, Wu KK, Wang LH (1994) Characterization of the Genomic Structure, Chromosomal Location and Promoter of Human Prostaglandin H Synthase-2 Gene. Biochemical and Biophysical Research Communications 203: 190-199.
40. Ramsay RG, Barton AL, Gonda TJ (2003) Targeting c-Myb expression in human disease. Expert Opinion on Therapeutic Targets 7: 235-248.
41. Liu F, Pan K, Zhang X, Zhang Y, Zhang L, et al. (2006) Genetic variants in cyclooxygenase-2: Expression and risk of gastric cancer and its precursors in a Chinese population. Gastroenterology 130: 1975-1984.
42. Zhang X, Miao X, Tan W, Ning B, Liu Z, et al. (2005) Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. Gastroenterology 129: 565-576.
43. Wang D, DuBois RN (2006) Prostaglandins and cancer. Gut 55: 115-122.
44. Fujita H, Koshida K, Keller ET, Takahashi Y, Yoshimito T, et al. (2002) Cyclooxygenase-2 promotes prostate cancer progression. The Prostate 53: 232-240.
45. Zha S, Yegnasubramanian V, Nelson WG, Isaacs WB, De Marzo AM (2004) Cyclooxygenases in cancer: progress and perspective. Cancer Letters 215: 1-20.
46. Papafili A, Hill MR, Brull DJ, McAnulty RJ, Marshall RP, et al. (2002) Common Promoter Variant in Cyclooxygenase-2 Represses Gene Expression: Evidence of Role in Acute-Phase Inflammatory Response. Arterioscler Thromb Vasc Biol 22: 1631-1636.
47. Kovesdi I, Reichel R, Nevins JR (1987) Role of an adenovirus E2 promoter binding factor in E1A-mediated coordinate gene control. Proc Natl Acad Sci USA 84: 2180-2184.
48. Davis JN, McCabe MT, Hayward SW, Park JM, Day ML (2005) Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells. Cancer Res 65: 3633-3642.
49. Szczeklik W, Sanak M, Szczeklik A (2004) Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma. J Allergy Clin Immunol 114: 248-253.